- Musculoskeletal Pain and the Prevalence of Rheumatoid Arthritis in Breast Cancer Patients During Cancer Treatment: A Retrospective Study
-
Kim JY, Kim MJ, Lee EB, Kim TY, Lee KH, Im SA, Park JK
- KMID: 2534777
- J Breast Cancer.
- 2022 Oct;25(5):404-414.
- doi: 10.4048/jbc.2022.25.e40
Purpose: Breast cancer patients often develop musculoskeletal pain, resembling that experienced by patients with rheumatoid arthritis (RA), during cancer treatment. This study aimed to investigate the causes of musculoskeletal pain,... -
- CITED
-
- Close
- SHARE
-
- Close
- Intensity Modulated Radiotherapy and Volumetric Modulated Arc Therapy in the Treatment of Breast Cancer: An Updated Review
-
Chang JS, Chang JH, Kim N, Kim YB, Shin KH, Kim K
- KMID: 2534773
- J Breast Cancer.
- 2022 Oct;25(5):349-365.
- doi: 10.4048/jbc.2022.25.e37
Radiation therapy (RT) plays a critical role in breast cancer treatment. In the modern technological era, innovations and progress in breast RT and delivery techniques have greatly improved the clinical... -
- CITED
-
- Close
- SHARE
-
- Close
- Multicentric Breast Cancer of the Axillary and Pectoral Breasts: A Case Report and Literature Review
-
Kim H, Ko EY, Han BK, Kim JY, Chae BJ, Lee H
- KMID: 2534780
- J Breast Cancer.
- 2022 Oct;25(5):436-442.
- doi: 10.4048/jbc.2022.25.e33
Multicentric cancer of the pectoral and ectopic breasts is extremely rare, and diagnosing this malignancy remains challenging because axillary breast cancer is easily misdiagnosed as lymph node metastasis. Moreover, there... -
- CITED
-
- Close
- SHARE
-
- Close
- Somatic Mutations of TP53 Identified by Targeted Next-Generation Sequencing Are Poor Prognostic Factors for Primary Operable Breast Cancer: A Single-Center Study
-
Park JH, Kwon MJ, Seo J, Kim HY, Min SK, Kim LS
- KMID: 2534775
- J Breast Cancer.
- 2022 Oct;25(5):379-386.
- doi: 10.4048/jbc.2022.25.e41
Few studies have reported on the clinical utility of targeted next-generation sequencing (NGS) for breast cancer in Korea. We retrospectively reviewed the targeted NGS data of 219 patients with breast... -
- CITED
-
- Close
- SHARE
-
- Close
- The Significance of p-AKT1 as a Prognostic Marker and Therapeutic Target in Patients With Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor-2-Positive Early Breast Cancer
-
Kim JY, Park CS, Jang SK, Seol H, Seong MK, Noh WC, Park IC, Kim HA
- KMID: 2534776
- J Breast Cancer.
- 2022 Oct;25(5):387-403.
- doi: 10.4048/jbc.2022.25.e43
Purpose: Phosphorylated AKT1 (p-AKT1) at Ser473 is a functional isoform of AKT and a key component of the PI3K/mTOR/AKT pathway. This study aimed to evaluate the prognostic significance of p-AKT1... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of Mobile Healthcare Applications on the Lifestyle of Patients With Breast Cancer: A Protocol for a Randomized Clinical Trial
-
Baek SY, Lee SB, Lee Y, Chung S, Choi CM, Lee HJ, Jo MW, Yun SC, Lee JW
- KMID: 2534779
- J Breast Cancer.
- 2022 Oct;25(5):425-435.
- doi: 10.4048/jbc.2022.25.e42
Purpose: Physical activity (PA) in patients with breast cancer is associated with improved quality of life (QoL); however, many breast cancer survivors do not meet the recommended PA level. This... -
- CITED
-
- Close
- SHARE
-
- Close
- Income Disparity in Breast Cancer Incidence and Stage at Presentation: A National Population Study of South Korea
-
Choe SA, Roh M, Kim HR, Lee S, Ki M, Paek D, Son M
- KMID: 2534778
- J Breast Cancer.
- 2022 Oct;25(5):415-424.
- doi: 10.4048/jbc.2022.25.e38
Purpose: This study aims to explore income-based disparities in breast cancer (BC) incidence and stage at presentation in a national population in South Korea, where a National Cancer Screening Program... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Application of Next-Generation Sequencing in Patients With Breast Cancer: Real-World Data
-
Suh KJ, Kim SH, Kim YJ, Shin H, Kang E, Kim EK, Lee S, Woo JW, Na HY, Ahn S, Jang BS, Kim IA, Park SY, Kim JH
- KMID: 2534774
- J Breast Cancer.
- 2022 Oct;25(5):366-378.
- doi: 10.4048/jbc.2022.25.e30
Purpose: Next-generation sequencing (NGS)-based tumor panel testing has been reimbursed by the Korean government since 2017. We evaluated the use of NGS-based tumor panel testing in real-world clinical practice, focusing... -
- CITED
-
- Close
- SHARE
-
- Close
